Proton pump inhibitor use and the antifracture efficacy of alendronate.

Abrahamsen B, Eiken P, Eastell R

DOI: 10.1001/archinternmed.2011.20
Published: 2011 Jun 13
Container: Archives of internal medicine
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1001/archinternmed.2011.20,
  title = {Proton pump inhibitor use and the antifracture efficacy of alendronate.},
  author = {Abrahamsen B and Eiken P and Eastell R},
  year = {2011},
  journal = {Archives of internal medicine},
  doi = {10.1001/archinternmed.2011.20},
  url = {https://doi.org/10.1001/archinternmed.2011.20}
}

RIS

TY  - JOUR
TI  - Proton pump inhibitor use and the antifracture efficacy of alendronate.
AU  - Abrahamsen B
AU  - Eiken P
AU  - Eastell R
PY  - 2011
JO  - Archives of internal medicine
DO  - 10.1001/archinternmed.2011.20
UR  - https://doi.org/10.1001/archinternmed.2011.20
ER  -

APA

B, A., P, E., & R, E. (2011). Proton pump inhibitor use and the antifracture efficacy of alendronate.. Archives of internal medicine. https://doi.org/10.1001/archinternmed.2011.20

Source records

pubmed · retrieved 2026-09-25T02:50:06.931Z